Withhold Gliptins From Diabetics With Heart Failure? – Medscape
Medscape |
Withhold Gliptins From Diabetics With Heart Failure?
Medscape BARCELONA, Spain — New data from EXAMINE, the cardiovascular-safety trial with the type 2 diabetes drug alogliptin (Nesina, Takeda Pharmaceuticals), has shown no significantly increased risk for heart failure (HF) with use of this dipeptidyl peptidase … |